Showing results (41-50 of 805) with videos related to
Sort By:
Pageof 81
Viral Immunology|May 25, 2012
TGF-β blockade does not improve control of an established persistent viral infectionTobias Boettler, Yang Cheng, Katrin Ehrhardt, et al.Novartis Foundation Symposium|February 11, 2009
Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell massFrank Waldron-Lynch, Matthias von Herrath, Kevan C HeroldFrontiers in Immunology|January 19, 2024
Immunological and virological triggers of type 1 diabetes: insights and implicationsJoana R N Lemos, Khemraj Hirani, Matthias von HerrathExpert Review of Anti-Infective Therapy|March 9, 2012
Can an immune-regulatory vaccine prevent HIV infection?Tobias Boettler, Edecio Cunha-Neto, Jorge Kalil, et al.Islets|September 22, 2012
The microbiology of human hygiene and its impact on type 1 diabetesNora M Chapman, Ken Coppieters, Matthias von Herrath, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 20, 2009
Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetesDamien Bresson, Matthew Fradkin, Yulia Manenkova, et al.Journal of Autoimmunity|November 9, 2011
Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatmentDamien Bresson, Georgia Fousteri, Yulia Manenkova, et al.Current Opinion in Endocrinology, Diabetes, and Obesity|June 8, 2021
Current state of antigen-specific immunotherapy for type 1 diabetesFrederik Flindt Kreiner, Bernt Johan von Scholten, Ken Coppieters, et al.Diabetology International|October 29, 2024
Type 1 diabetes: immune pathology and novel therapeutic approachesEleanor M Ling, Joana R N Lemos, Khemraj Hirani, et al.Viral Immunology|June 23, 2010
Minimal effect of CD103 expression on the control of a chronic antiviral immune responseGeorgia Fousteri, Amy Dave, Therese Juntti, et al.Pageof 81